Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yifu Ma

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Pharmacology|December 19, 2024
Deep brain stimulation combined with morroniside promotes neural plasticity and motor functional recovery after ischemic strokeYanxi Chen, Zhidong Xu, Yifu Ma, et al.
Cell Death & Disease|February 15, 2024
Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8<sup>+</sup> T cellsChenfeng Han, Minmin Ge, Pengfei Xing, et al.
BMJ Open|March 8, 2024
Evaluation of the efficacy and safety of a precise thymalfasin-regulated PRaG regimen for advanced refractory solid tumours: protocol for the open-label, prospective, multicentre study (PRaG5.0 study)Yuehong Kong, Rongzheng Chen, Meiling Xu, et al.
Technology in Cancer Research & Treatment|July 25, 2024
Phase I/II Clinical Study of PRaG Regimen Combined With Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors With Cancerous Ascites (PRaG4.0P Study)Yingying Xu, Yuehong Kong, Yifu Ma, et al.
Frontiers in Immunology|July 25, 2022
PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II StudyYuehong Kong, Xiangrong Zhao, Meiling Xu, et al.
Science Immunology|May 1, 2026
Citraconate preserves T cell stemness and antitumor immunityWenhui Li, Minmin Ge, Ziyi Luo, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Pharmacology|December 19, 2024
Deep brain stimulation combined with morroniside promotes neural plasticity and motor functional recovery after ischemic strokeYanxi Chen, Zhidong Xu, Yifu Ma, et al.
Cell Death & Disease|February 15, 2024
Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8<sup>+</sup> T cellsChenfeng Han, Minmin Ge, Pengfei Xing, et al.
BMJ Open|March 8, 2024
Evaluation of the efficacy and safety of a precise thymalfasin-regulated PRaG regimen for advanced refractory solid tumours: protocol for the open-label, prospective, multicentre study (PRaG5.0 study)Yuehong Kong, Rongzheng Chen, Meiling Xu, et al.
Technology in Cancer Research & Treatment|July 25, 2024
Phase I/II Clinical Study of PRaG Regimen Combined With Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors With Cancerous Ascites (PRaG4.0P Study)Yingying Xu, Yuehong Kong, Yifu Ma, et al.
Frontiers in Immunology|July 25, 2022
PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II StudyYuehong Kong, Xiangrong Zhao, Meiling Xu, et al.
Science Immunology|May 1, 2026
Citraconate preserves T cell stemness and antitumor immunityWenhui Li, Minmin Ge, Ziyi Luo, et al.
Pageof 2